Chemoinformaics analysis of 14-Hydroxygelsenicine
Molecular Weight | 342.395 | nRot | 2 |
Heavy Atom Molecular Weight | 320.219 | nRig | 24 |
Exact Molecular Weight | 342.158 | nRing | 6 |
Solubility: LogS | -3.897 | nHRing | 4 |
Solubility: LogP | 1.89 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 4 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 4 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 19 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 5 | APOL | 51.8074 |
nHD | 1 | BPOL | 28.1206 |
QED | 0.883 |
Synth | 6.375 |
Natural Product Likeliness | 2.427 |
NR-PPAR-gamma | 0.007 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.918 |
Pgp-sub | 0.022 |
HIA | 0.012 |
CACO-2 | -4.851 |
MDCK | 0.0000526 |
BBB | 0.935 |
PPB | 0.503804 |
VDSS | 0.953 |
FU | 0.321158 |
CYP1A2-inh | 0.013 |
CYP1A2-sub | 0.827 |
CYP2c19-inh | 0.03 |
CYP2c19-sub | 0.946 |
CYP2c9-inh | 0.013 |
CYP2c9-sub | 0.268 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.206 |
CYP3a4-inh | 0.116 |
CYP3a4-sub | 0.911 |
CL | 7.425 |
T12 | 0.043 |
hERG | 0.031 |
Ames | 0.828 |
ROA | 0.824 |
SkinSen | 0.052 |
Carcinogencity | 0.897 |
EI | 0.01 |
Respiratory | 0.816 |
NR-Aromatase | 0.952 |
Antiviral | No |
Prediction | 0.517748 |